LU74763A1 - - Google Patents

Info

Publication number
LU74763A1
LU74763A1 LU74763A LU74763A LU74763A1 LU 74763 A1 LU74763 A1 LU 74763A1 LU 74763 A LU74763 A LU 74763A LU 74763 A LU74763 A LU 74763A LU 74763 A1 LU74763 A1 LU 74763A1
Authority
LU
Luxembourg
Application number
LU74763A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of LU74763A1 publication Critical patent/LU74763A1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • C07D307/935Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • External Artificial Organs (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Furan Compounds (AREA)
  • Pyridine Compounds (AREA)
LU74763A 1975-04-18 1976-04-14 LU74763A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19752517771 DE2517771A1 (de) 1975-04-18 1975-04-18 Neue prostaglandin-acetylen-analoga und verfahren zu ihrer herstellung

Publications (1)

Publication Number Publication Date
LU74763A1 true LU74763A1 (de) 1977-01-12

Family

ID=5944669

Family Applications (1)

Application Number Title Priority Date Filing Date
LU74763A LU74763A1 (de) 1975-04-18 1976-04-14

Country Status (15)

Country Link
US (1) US4073934A (de)
JP (1) JPS51131860A (de)
AT (1) AT360182B (de)
AU (1) AU510088B2 (de)
BE (1) BE840872A (de)
CA (1) CA1079725A (de)
CH (1) CH626876A5 (de)
DE (1) DE2517771A1 (de)
DK (1) DK142976A (de)
FR (1) FR2307525A1 (de)
GB (1) GB1549047A (de)
IE (1) IE43600B1 (de)
LU (1) LU74763A1 (de)
NL (1) NL7604016A (de)
SE (1) SE7604409L (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2517772A1 (de) * 1975-04-18 1976-10-28 Schering Ag Cyclopentanderivate und verfahren zu ihrer herstellung
US4268522A (en) * 1976-06-14 1981-05-19 Pfizer Inc. 13,14-Dihydro-15-alkenyl- and 13,14-dihydro-15-alkynyl prostaglandins and analogs thereof
DE2729960A1 (de) * 1977-06-30 1979-01-18 Schering Ag Neue acetylenprostaglandine und verfahren zu ihrer herstellung
JPS6033429B2 (ja) * 1980-04-28 1985-08-02 小野薬品工業株式会社 プロスタグランジン類似化合物
GB2225573A (en) * 1988-09-16 1990-06-06 Ueno Seiyaku Oyo Kenkyujo Kk 13,14-dihydro-15-keto-PGFs
WO1999012898A1 (en) * 1997-09-09 1999-03-18 The Procter & Gamble Company Aromatic c16-c20-substituted tetrahydro prostaglandins useful as fp agonists
US5977173A (en) * 1997-09-09 1999-11-02 Wos; John August Aromatic C16 -C20 -substituted tetrahydro prostaglandins useful as FP agonists
EP1159266B1 (de) * 1999-03-05 2004-11-03 Duke University C-16 ungesätigte fp-selektive prostaglandin analoge
AU3861700A (en) * 1999-03-05 2000-09-21 Procter & Gamble Company, The Aldehyde intermediates for the preparation of prostaglandin derivatives
US6894175B1 (en) * 1999-08-04 2005-05-17 The Procter & Gamble Company 2-Decarboxy-2-phosphinico prostaglandin derivatives and methods for their preparation and use
US20020037914A1 (en) * 2000-03-31 2002-03-28 Delong Mitchell Anthony Compositions and methods for treating hair loss using C16-C20 aromatic tetrahydro prostaglandins
US20020172693A1 (en) 2000-03-31 2002-11-21 Delong Michell Anthony Compositions and methods for treating hair loss using non-naturally occurring prostaglandins
US20020146439A1 (en) * 2000-03-31 2002-10-10 Delong Mitchell Anthony Compositions and methods for treating hair loss using oximyl and hydroxylamino prostaglandins
US20020013294A1 (en) 2000-03-31 2002-01-31 Delong Mitchell Anthony Cosmetic and pharmaceutical compositions and methods using 2-decarboxy-2-phosphinico derivatives
US7461968B2 (en) * 2003-10-30 2008-12-09 Deka Products Limited Partnership System, device, and method for mixing liquids
US8722739B2 (en) 2008-10-29 2014-05-13 Novaer Holdings, Inc. Amino acid salts of prostaglandins
US8623918B2 (en) 2008-10-29 2014-01-07 Novaer Holdings, Inc. Amino acid salts of prostaglandins
US20110293549A1 (en) 2009-02-03 2011-12-01 Athena Cosmetics, Inc. Composition, method and kit for enhancing hair
CN106748951B (zh) 2012-07-19 2020-07-24 开曼化学股份有限公司 作为在治疗ep4介导的疾病和病状中使用的ep4受体选择性激动剂的二氟内酰胺化合物
SG11201507470WA (en) 2013-03-15 2015-10-29 Cayman Chemical Co Inc Lactam compounds as ep4 receptor-selective agonists for use in the treatment of ep4-mediated diseases and conditions
AU2014229065B2 (en) 2013-03-15 2017-03-09 Cayman Chemical Company, Inc. Methods of synthesizing a difluorolactam analog
AU2014290512A1 (en) 2013-07-19 2015-11-12 Cayman Chemical Company, Inc. Methods, systems, and compositions for promoting bone growth
PT3456710T (pt) 2016-05-09 2021-09-02 Agc Inc Novo derivado de prostaglandina
CA3079807A1 (en) 2017-10-31 2019-05-09 AGC Inc. Method for producing prostaglandin derivative

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS50140427A (de) * 1974-02-27 1975-11-11

Also Published As

Publication number Publication date
NL7604016A (nl) 1976-10-20
BE840872A (fr) 1976-10-18
JPS51131860A (en) 1976-11-16
IE43600L (en) 1976-10-18
DE2517771A1 (de) 1976-10-28
SE7604409L (sv) 1976-10-19
AU510088B2 (en) 1980-06-05
FR2307525A1 (fr) 1976-11-12
AT360182B (de) 1980-12-29
DK142976A (da) 1976-10-19
AU1314876A (en) 1977-10-27
CA1079725A (en) 1980-06-17
CH626876A5 (de) 1981-12-15
FR2307525B1 (de) 1980-11-28
GB1549047A (en) 1979-08-01
IE43600B1 (en) 1981-04-08
ATA273976A (de) 1980-05-15
US4073934A (en) 1978-02-14

Similar Documents

Publication Publication Date Title
JPS5320368B2 (de)
JPS614813B2 (de)
FR2307525B1 (de)
FR2300557B1 (de)
JPS5188181A (de)
JPS5640856B2 (de)
JPS5270499U (de)
JPS5187484A (de)
CH601099A5 (de)
CH601481A5 (de)
CH602123A5 (de)
CH603697A5 (de)
CH600132A5 (de)
CH599899A5 (de)
CH599588B5 (de)
CH599481A5 (de)
CH599439A5 (de)
CH599384A5 (de)
CH599378A5 (de)
CH599297A5 (de)
CH598746A5 (de)
CH602382A5 (de)
CH596588A5 (de)
CH596385A5 (de)
CH602458A5 (de)